Withdrawal Syndrome
14 drugs1,188 FAERS reportsMedDRA PT
GET
/api/v1/reaction/withdrawal-syndromeReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D013375
Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
Source: U.S. National Library of Medicine — MeSH (Substance Withdrawal Syndrome)
Drugs reporting Withdrawal Syndrome (14)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Capsicum Oleoresin522%
- 2Rosemary Oil713%
- 3Nefazodone129.9%
- 4Potassium Gluconate28.0%
- 5Lofexidine106.3%
- 6Lecithin55.1%
- 7Viloxazine454.6%
- 8Quazepam113.7%
- 9Levorphanol123.3%
- 10Desvenlafaxine7322.8%
- 11Samidorphan372.5%
- 12Polistirex352.0%
- 13Dexmedetomidine1081.7%
- 14Oxymorphone1671.4%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Drug Withdrawal Syndrome6 shared · 0.21
- Immune Thrombocytopenia2 shared · 0.13
- Crying2 shared · 0.10
- Dependence2 shared · 0.09
- Delirium2 shared · 0.08
- Product Availability Issue2 shared · 0.07
- Blister3 shared · 0.07
- Ill-defined Disorder2 shared · 0.06
- Inappropriate Schedule Of Drug Administration2 shared · 0.06
- Agitation3 shared · 0.05
Literature
Recent PubMed references pinned to Substance Withdrawal Syndrome as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Toolkit to prompt and support stopping antidepressants in general practice: an interview study exploring patient participants' experiences in the RELEASE trial.BMJ open · 2026 · Moura Ferreira P, McDonald S, Wallis KA, et al.PMID 42167941DOI 10.1136/bmjopen-2026-116702
- Opioid and α(2)-adrenoceptors interaction on the lethality, antinociception, antinociceptive tolerance, and precipitated withdrawal in mice treated with fentanyl and xylazine.Drug and alcohol dependence · 2026 · Albores-García D, Cruz SLPMID 42107142DOI 10.1016/j.drugalcdep.2026.113187
- Activation of TGF-β/ALK5/SMAD signaling alleviates behavioral and neurochemical deficits in tramadol withdrawal.Toxicology and applied pharmacology · 2026 · Wani SN, Grewal AK, Sharma O, et al.PMID 42097514DOI 10.1016/j.taap.2026.117849
- Alcohol Withdrawal Seizures: Neurobiological Mechanisms, Clinical Predictors, and Evidence- Based Management.Journal of psychiatric practice · 2026 · Skryabin V, Malygina A, Sokolova S, et al.PMID 42095715DOI 10.1097/PRA.0000000000000927
- Longitudinal Study of Plasma NFL and GFAP as Biomarkers of Alcohol Withdrawal-Associated Brain Injury.Addiction biology · 2026 · Clergue-Duval V, Questel F, Dereux A, et al.PMID 42070965DOI 10.1111/adb.70157
- Patient experiences and perceived efficacy of a newly implemented hospital-based withdrawal management unit in Vancouver, Canada: findings from the Road to Recovery evaluation.Addiction science & clinical practice · 2026 · Roberge S, Nolan S, Johnson C, et al.PMID 42062877DOI 10.1186/s13722-026-00671-5
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.